2011
DOI: 10.2165/11587160-000000000-00000
|View full text |Cite
|
Sign up to set email alerts
|

Role of Irbesartan in Prevention of Post-Coronary Artery Bypass Graft Atrial Fibrillation

Abstract: Pretreatment with irbesartan tends to have a significant protective effect against the occurrence of AF during the post-operative period in patients undergoing CABG.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 38 publications
0
6
0
Order By: Relevance
“…Consequently, 11 unique studies characterizing a total of 27 885 unique patients (median age, 65 years [range, 58.5-74.5 years]; 74.4% male and 25.6% female) were selected into our meta-analysis. 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 The baseline characteristics of included studies are summarized in Table 1 , and quality assessment for included trials is presented in eTable 1 in the Supplement . Outcome data of included studies were extracted and are detailed in eTable 2 in the Supplement .…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Consequently, 11 unique studies characterizing a total of 27 885 unique patients (median age, 65 years [range, 58.5-74.5 years]; 74.4% male and 25.6% female) were selected into our meta-analysis. 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 The baseline characteristics of included studies are summarized in Table 1 , and quality assessment for included trials is presented in eTable 1 in the Supplement . Outcome data of included studies were extracted and are detailed in eTable 2 in the Supplement .…”
Section: Resultsmentioning
confidence: 99%
“…The remaining 287 full-text articles were screened further for eligibility, and 276 were excluded through predefined inclusion criteria. Consequently, 11 unique studies characterizing a total of 27 885 unique patients (median age, 65 years [range, 58.5-74.5 years]; 74.4% male and 25.6% female) were selected into our meta-analysis . The baseline characteristics of included studies are summarized in Table 1, and quality assessment for included trials is presented in eTable 1 in the Supplement.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…It is generally believed that AT1R blockers (ARBs) protect heart by lowering blood pressure. However, recent studies showed that ARBs had effects on preventing the occurrence of arrhythmia, effectively reducing the mortality among patients with atrial fibrillation (AF) (El-Haddad et al, 2011;Heckbert et al, 2009;Tveit et al, 2007). Treatment with ARBs was more effective than beta-blockers in reducing the AF risk and the incidence of recurrent AF (Cuspidi et al, 2008).…”
Section: Introductionmentioning
confidence: 99%